Profile: Lentigen Corporation is a biologics company that focuses on the development of breakthrough treatments for human disease. We focus on the development of VLP vaccines for both pandemic & seasonal influenza, and the same technology can be used for the production of vaccines for other diseases. We use the lentiviral vector technology to the development of production methods for a range of proteins and antibodies that include erythropoietin for the treatment of anemia, factor VIII for the treatment of hemophilia A & recombinant diagnostic anti-anthrax antibodies.